CONNECT WITH US
Tech

Tech

Break Out the Blue Mushrooms: ‘Common Side Effects’ Will Return in January

Gizmodo - Tech logo

Published on

Add as a preferred source on Google
Break Out the Blue Mushrooms: ‘Common Side Effects’ Will Return in January

At San Diego Comic-Con in July, we learned that Common Side Effects would be returning in early 2027. Adult Swim has made good on that promise by announcing at New York Comic Con that the trippy animated series about a mushroom with miraculous healing powers—and the chaos surrounding it—will premiere its second season on January 24.

Common Side Effects comes from executive producers Greg Daniels and Mike Judge (King of the Hill; Judge also does one of the voices) and co-creators Joe Bennett (Scavengers Reign) and Steve Hely.

When last we saw our ragtag heroes in the Peabody Award-winning show, Marshall (Dave King) and Frances (Emily Pendergast) had just reunited in the California desert—as fugitives on the run. But that surely won’t last long with DEA Agent Harrington (Martha Kelly) in hot pursuit.

Meanwhile, Harrington’s partner, Agent Copano (Joseph Lee Anderson), is recovering from injuries suffered in a raid gone wrong on a farm secretly cultivating the “Blue Angel,” the mushroom discovered by Marshall that can heal any wound or sickness, including death. Of course, there are some… common side effects, which are definitely going to come into play in season two. The aftermath of that raid, and the clashing interests of everyone who wants to get their hands on the mushroom, are also poised for some ripe exploration.

“At Adult Swim, we always put our faith not just in talented creators who are driven to push animation into new territory, but also in a fanbase that we know will show up and embrace the new without hesitation,” Adult Swim president Michael Ouweleen said in a press release.


Source link
Related Topics:Tech

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.